Aion Therapeutic Inc.
ANTCF
$0.0052
$0.000.00%
| 07/31/2022 | 04/30/2022 | 01/31/2022 | 10/31/2021 | 07/31/2021 | |
|---|---|---|---|---|---|
| Revenue | -- | -- | -- | -- | -- |
| Total Other Revenue | -- | -- | -- | -- | -- |
| Total Revenue | -- | -- | -- | -- | -- |
| Cost of Revenue | -- | -- | -- | -- | -- |
| Gross Profit | -- | -- | -- | -- | -- |
| SG&A Expenses | 238.20K | 226.10K | 226.70K | 332.60K | 310.00K |
| Depreciation & Amortization | 4.30K | 1.30K | 13.80K | 18.40K | 18.80K |
| Other Operating Expenses | -- | -- | -- | -- | -- |
| Total Operating Expenses | 242.60K | 979.80K | 240.50K | 351.00K | 555.50K |
| Operating Income | -242.60K | -979.80K | -240.50K | -351.00K | -555.50K |
| Income Before Tax | 628.20K | -1.28M | -513.90K | -637.80K | -607.80K |
| Income Tax Expenses | -- | -- | -- | -- | -- |
| Earnings from Continuing Operations | 628.20K | -1.28M | -513.90K | -637.80K | -607.80K |
| Earnings from Discontinued Operations | -- | -- | -- | -- | -- |
| Extraordinary Item & Accounting Change | -- | -- | -- | -- | -- |
| Minority Interest in Earnings | -- | -- | -- | -- | -- |
| Net Income | 628.20K | -1.28M | -513.90K | -637.80K | -607.80K |
| EBIT | -242.60K | -979.80K | -240.50K | -351.00K | -555.50K |
| EBITDA | -238.20K | -978.60K | -226.70K | -332.60K | -536.70K |
| EPS Basic | 0.00 | -0.01 | 0.00 | 0.00 | 0.00 |
| Normalized Basic EPS | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| EPS Diluted | 0.00 | -0.01 | 0.00 | 0.00 | 0.00 |
| Normalized Diluted EPS | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| Average Basic Shares Outstanding | 143.71M | 141.74M | 141.80M | 141.80M | 134.23M |
| Average Diluted Shares Outstanding | 178.12M | 141.74M | 141.80M | 141.80M | 134.23M |
| Dividend Per Share | -- | -- | -- | -- | -- |
| Payout Ratio | -- | -- | -- | -- | -- |
